Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The extracellular matrix as a mediator of cell-cell communication in cardiovascular inflammation

Project description

Insight into the role of the extracellular matrix in cardiovascular disease

The extracellular matrix (ECM) is a large network of proteins and other molecules that support and organise cells into tissues in the body. ECM is also emerging as a communication hub that transduces mechanical stimuli and facilitates cell-cell-interaction. Funded by the European Research Council, the MATRICARD project is interested in the role of ECM in cardiovascular disease. Researchers will therefore investigate the ECM composition during inflammatory conditions such as atherosclerosis and myocardial infarction and how it may influence disease progression. Project results will provide important knowledge on the mechanisms that regulate ECM in health and disease while the identification of therapeutic targets will help prevent cardiovascular disease.

Objective

Cardiovascular diseases, as coronary artery disease (CAD) and its sequelae myocardial infarction (MI) and heart failure, represent the leading cause of morbidity and mortality in industrialized and developing countries. Atherosclerosis is the pathology causing CAD and MI; both are characterized by a sterile inflammation with a chronic and acute course of the disease, respectively. There is a plethora of cell types, as leukocytes, endothelial cells, vascular smooth muscle cells, platelets, fibroblasts, and cardiomyocytes, which play important roles in the initiation, propagation, and termination of the pathophysiological processes. Recent data from genetic studies found that genetic variation influencing extracellular matrix (ECM) proteins is associated with cardiovascular diseases. We found that such proteins which are secreted by one cell type influence phenotypes of other cell types via, e.g. silencing of inflammatory functions or modulation of ECM composition. The ECM hence not only represents a meshwork in which cells are organized but also a communication hub to transduce mechanical stimuli and cell-cell-interaction signals. Here, we aim to explore the ECM proteome in sterile inflammatory diseases as atherosclerosis and MI in an unprecedented depth. We aim to identify novel regulators which give insights into the underlying processes and we will study the molecular and cellular mechanisms modifying the course of the disease. This will lead to the identification of novel therapeutic targets which might reshape our understanding of how these diseases occur and how we can prevent them, and to the development of novel, individualized treatment strategies. Finally, we aim to translate our findings to humans to get first insights on whether these strategies can be adapted and used in clinical trials. MATRICARD will go beyond technical boundaries and lead to a deep knowledge of ECM-mediated cell-cell-communication and reveal its translational potential.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-STG

See all projects funded under this call

Host institution

UNIVERSITAT DES SAARLANDES
Net EU contribution
€ 518 875,00
Address
CAMPUS
66123 Saarbrucken
Germany
Region
Saarland Saarland Regionalverband Saarbrücken
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 518 875,00

Beneficiaries (2)